William Hoffman, Director at Inari Medical, Inc. (NARI), sold 76,898 shares at $41.94 ($3.2M) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($3.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.94 | 35,858 | $1.5M | 46.6% |
| 2 | $41.94 | 35,858 | $1.5M | 46.6% |
| 3 | $42.73 | 2,491 | $106K | 3.3% |
| 4 | $42.73 | 2,491 | $106K | 3.3% |
| 5 | $43.61 | 200 | $9K | 0.3% |
| Total | $42.00 avg | 76,898 |
| $3.2M |
| 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |